PSI is one of many organisations that are rooted within statistics and data analytics. As such, we believe that it is important for us to link with other appropriate organisations.
PSI is the association located in the UK for statisticians in the pharmaceutical industry, and therefore we have two representatives on the European Federation of Statisticians in the Pharmaceutical Industry council. EFSPI brings together representatives of statistical associations within Europe.
PSI has a joint award for Statistical Excellence within the Pharmaceutical Industry with the RSS. There are six-monthly meetings between representatives of both organisations to maintain good communication and identify opportunities to work together.
Recently PSI has linked with the Indian Association for Statistics in Clinical Trials (IASCT) and members of IASCT can join PSI at a reduced rate. PSI also welcomes members from any other countries, and from statisticians working in the wider clinical research and healthcare industries.
PSI has representatives on the Council of Biopharmaceutical Statisticians.
The Special Interest Groups include suitable representatives from, and interacts with, other organisations depending on the SIG topic. For instance, the Data Transparency SIG has had discussions with PhUSE members.
The PSI Careers and Academic Liaison Committee (CALC) promotes careers for statisticians and programmers within the pharmaceutical industry, and provides information and insights for those who might want to consider such a career through school and university activities, establishing links with relevant professional groups and via our Careers and Schools/Education websites.
The PSI Regulatory Committee is a joint PSI/EFSPI Committee which aims to provide an industry viewpoint on regulatory issues linked to statistics. This includes promoting best practice, reviewing and collating comments on regulatory policy and guidelines, driving debate on future guidance, and engaging with statisticians in European regulatory agencies, including the EMA Biostatistics Working Party (BSWP), as well as the statistical assessors at the Medicines & Healthcare products Regulatory Agency (MHRA).
PSI recognises that it is part of a wide community and therefore actively engages with the community.
In this webinar we will explain the how to understand the sequences of issues and how to fix it in order to drastically improve the replicability of the results. Through example the presentation will cover concepts such as OFAT vs DoE, p-values and Bayesian statistics and Power vs Assurance as easy opportunities to improve robustness of decisions.
This webinar will feature presentations from 3 speakers on the topic of Using Visualisations to Help Make Decisions.
The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2020 to July 2021 to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 - 4 sessions in the UK. It promises to be a truly memorable course.
In this webinar you will hear an introduction to what a patient preference study is as well as an overview of where this type of study can inform regulatory decision making. This will be followed by 2 examples looking at potential approaches to eliciting patient preference.
This course is aimed at Statisticians and Programmers experienced in SAS, but little or no experience with R. An Introduction to R studio and the R language, statistical graphics, programming statistical models, simulations and more…
PSI Toxicology SIG workshop – 24th and 25th November 2020 The Toxicology SIG provides a forum for statisticians working in regulatory/investigative toxicology, as well as most other pre-clinical areas, to discuss issues and interact with one another. This 1.5-day workshop will involve approximately 20 statisticians, focusing on discussions around “best practice” in the statistical analysis of various data types. The afternoon of Day 1 will include a 4.5 hour Bayesian training course focused towards applications in toxicology/pre-clinical, provided by Prof. Dr. Katja Ickstadt and is included in the workshop fee. The cost will be £270 including VAT per delegate, inclusive of food and one night’s accommodation (and the training course). The workshop is being held at the Crowne Plaza Hotel, Heathrow. The agenda and topics that will be discussed are yet to be finalised, but please get in touch with gareth.thomas@covance.com if you have suggestions. Full details will be circulated in the coming weeks.
GSK has a thriving global community of Oncology statisticians supporting our commitment to the development of new oncology therapies with the life-changing potential of helping patients with cancer. Click to learn about our exciting career opportunities.
GSK has a thriving global community of Oncology statisticians supporting our commitment to the development of new oncology therapies with the life-changing potential of helping patients with cancer. Click to learn about our exciting career opportunities.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.
GSK has a thriving global community of Oncology statisticians supporting our commitment to the development of new oncology therapies with the life-changing potential of helping patients with cancer. Click to learn about our exciting career opportunities.
We offer an interesting, diversified and challenging position, good contractual conditions, flexible working models, all the social benefits of a modern company and a professional environment where you will have the opportunity for personal growth.
We offer an interesting, diversified and challenging position, good contractual conditions, flexible working models, all the social benefits of a modern company and a professional environment where you will have the opportunity for personal growth.
Wish you were here? Recognised recently as a Top CRO by Life Science Leader, Premier Research is a medium sized, full service, global CRO with circa 1,500 employees worldwide, perfectly positioned to be big enough to help, yet small enough to care.
We currently have vacancies in our Early Phase and Late Phase Teams, for either home or office based positions across EMEA, so please reach out for more information.
Why not come and work for a company recognised as one of the UK's Top 25 Best Big Companies to Work For. The continued growth of our pipeline means we have opportunities for exceptional statisticians at all levels to join our Biostatistics group.
